VYGR

Voyager Therapeutics (VYGR)

Voyager Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VYGR

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/14	05:01	GlobeNewswire Inc.	Voyager Therapeutics to Present at Multiple Virtual Investor Conferences	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/06/13	20:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/06/13	20:00	GlobeNewswire Inc.	Voyager Therapeutics Announces Appointment of Nathan Jorgensen as Chief Financial Officer	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/06/08	05:22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/06/08	05:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/06/08	05:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/06/08	05:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/06/08	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/06/07	05:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/05/16	20:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/05/16	20:00	GlobeNewswire Inc.	Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer’s Disease	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/05/14	05:01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/05/14	05:01	GlobeNewswire Inc.	Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/05/14	05:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/05/08	19:00	GlobeNewswire Inc.	Voyager Therapeutics Presents Data for Second-Generation, TRACER™-Generated Capsids and CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/05/06	20:00	GlobeNewswire Inc.	Voyager Therapeutics Announces First Quarter 2024 Conference Call and Webcast	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/04/23	05:30	GlobeNewswire Inc.	Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/04/16	20:00	GlobeNewswire Inc.	Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/03/27	05:01	GlobeNewswire Inc.	Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/03/13	20:00	GlobeNewswire Inc.	Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/02/29	06:01	GlobeNewswire Inc.	Voyager Therapeutics Reports Fourth Quarter and Full Year 2023 Financial and Operating Results	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/02/29	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/02/26	21:00	GlobeNewswire Inc.	Voyager Therapeutics Announces Selection of Gene Therapy Development Candidate for Friedreich’s Ataxia in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/02/23	06:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/02/23	06:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/02/22	05:16	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/02/22	05:13	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/02/21	21:00	GlobeNewswire Inc.	Voyager Therapeutics Announces Fourth Quarter 2023 Conference Call and Webcast	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/02/21	05:11	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:VYGR	Voyager Therapeutics Inc
2024/02/20	21:00	GlobeNewswire Inc.	Voyager Therapeutics Reports Robust Preclinical Activity in Tau Silencing Gene Therapy Program for Alzheimer’s Disease and Advances Program into Late Research	NASDAQ:VYGR	Voyager Therapeutics Inc